Blood lead levels and death from all causes, cardiovascular disease, and cancer: results from the NHANES III mortality study
- PMID: 17035139
- PMCID: PMC1626441
- DOI: 10.1289/ehp.9123
Blood lead levels and death from all causes, cardiovascular disease, and cancer: results from the NHANES III mortality study
Abstract
Background: Analyses of mortality data for participants examined in 1976-1980 in the second National Health and Nutrition Examination Survey (NHANES II) suggested an increased risk of mortality at blood lead levels > 20 microg/dL. Blood lead levels have decreased markedly since the late 1970s. In NHANES III, conducted during 1988-1994, few adults had levels > 20 microg/dL.
Objective: Our objective in this study was to determine the risk of mortality in relation to lower blood lead levels observed for adult participants of NHANES III.
Methods: We analyzed mortality information for 9,757 participants who had a blood lead measurement and who were > or = 40 years of age at the baseline examination. Using blood lead levels categorized as < 5, 5 to < 10, and > or = 10 microg/dL, we determined the relative risk of mortality from all causes, cancer, and cardiovascular disease through Cox proportional hazard regression analysis.
Results: Using blood lead levels < 5 microg/dL as the referent, we determined that the relative risk of mortality from all causes was 1.24 [95% confidence interval (CI), 1.05-1.48] for those with blood levels of 5-9 microg/dL and 1.59 (95% CI, 1.28-1.98) for those with blood levels > or = 10 microg/dL (p for trend < 0.001). The magnitude of risk was similar for deaths due to cardiovascular disease and cancer, and tests for trend were statistically significant (p < 0.01) for both causes of death.
Conclusion: In a nationally representative sample of the U.S. population, blood lead levels as low as 5-9 mug/dL were associated with an increased risk of death from all causes, cardiovascular disease, and cancer.
Figures
References
-
- Annest JL, Pirkle JL, Makuc D, Neese JW, Bayse DD, Kovar MG. Chronological trend in blood lead levels between 1976 and 1980. N Engl J Med. 1983;308:1373–1377. - PubMed
-
- ATSDR 1999. Toxicological Profile for Lead. Atlanta, GA:Agency for Toxic Substances and Disease Registry. - PubMed
-
- CDC (Centers for Disease Control and Prevention) 1994. Plan and Operation of the Third National Health and Nutrition Examination Survey, 1988–94. Vital Health Stat 1(32). Available: http://www.cdc.gov/nchs/data/series/sr_01/sr01_032.pdf [accessed 21 August 2006].
-
- CDC (Centers for Disease Control and Prevention) Update: blood lead levels—United States, 1991–1994. MMWR Morb Mortal Wkly Rep. 1997;46:141–146. - PubMed
-
- Cheng Y, Schwartz J, Sparrow D, Aro A, Weiss ST, Hu H. Bone lead and blood lead levels in relation to baseline blood pressure and the prospective development of hypertension. The Normative Aging Study. Am J Epidemiol. 2001;153:164–171. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources